PT  - JOURNAL ARTICLE
AU  - SILVIA RIONDINO
AU  - PATRIZIA FERRONI
AU  - ANTONELLA SPILA
AU  - JHESSICA ALESSANDRONI
AU  - ROBERTA D'ALESSANDRO
AU  - VINCENZO FORMICA
AU  - DAVID DELLA-MORTE
AU  - RAFFAELE PALMIROTTA
AU  - UMBERTO NANNI
AU  - MARIO ROSELLI
AU  - FIORELLA GUADAGNI
TI  - Ensuring Sample Quality for Biomarker Discovery Studies – Use of ICT Tools to Trace Biosample Life-cycle
DP  - 2015 Nov 01
TA  - Cancer Genomics - Proteomics
PG  - 291--299
VI  - 12
IP  - 6
4099  - http://cgp.iiarjournals.org/content/12/6/291.short
4100  - http://cgp.iiarjournals.org/content/12/6/291.full
SO  - Cancer Genomics Proteomics2015 Nov 01; 12
AB  - The growing demand of personalized medicine marked the transition from an empirical medicine to a molecular one, aimed at predicting safer and more effective medical treatment for every patient, while minimizing adverse effects. This passage has emphasized the importance of biomarker discovery studies, and has led sample availability to assume a crucial role in biomedical research. Accordingly, a great interest in Biological Bank science has grown concomitantly. In biobanks, biological material and its accompanying data are collected, handled and stored in accordance with standard operating procedures (SOPs) and existing legislation. Sample quality is ensured by adherence to SOPs and sample whole life-cycle can be recorded by innovative tracking systems employing information technology (IT) tools for monitoring storage conditions and characterization of vast amount of data. All the above will ensure proper sample exchangeability among research facilities and will represent the starting point of all future personalized medicine-based clinical trials.